Atara Biotherapeutics Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. Stay up-to-date on Atara Biotherapeutics, Inc. Common Stock (ATRA) news with the latest updates, breaking headlines, news articles, and more from around the. View the ATRA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Atara Biotherapeutics. Research Atara Biotherapeutics' (Nasdaq:ATRA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Atara Biotherapeutics Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A.
Institutional Ownership and Shareholders. Atara Biotherapeutics, Inc. (US:ATRA) has 62 institutional owners and shareholders that have filed 13D/G or 13F forms. Atara Biotherapeutics is traded on the NASDAQ stock exchange under the symbol “ATRA”. When did Atara Biotherapeutics go public? Atara Biotherapeutics went. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. (NASDAQ: ATRA) Atara Biotherapeutics currently has 4,, outstanding shares. With Atara Biotherapeutics stock trading at $ per share, the total value of. See the latest Atara Biotherapeutics Inc stock price (ATRA:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Investors & Media · Latest News · Latest Presentation · Recent Event · Latest Financial Results · Latest Annual Filing · Email Alerts · Company Overview · Stock. Discover real-time Atara Biotherapeutics, Inc. Common Stock (ATRA) stock prices, quotes, historical data, news, and Insights for informed trading and. Stock analysis for Atara Biotherapeutics Inc (AT2:GR) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Atara Biotherapeutics Inc. (ATRA) Stock Performance ; Atara Biotherapeutics (ATRA). , ; BSE Sensex. , ; S&P Small-Cap · , Real-time Price Updates for Atara Biotherap (ATRA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. On Friday 08/23/ the closing price of the Atara Biotherapeutics Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/23/.
Stock analysis for Atara Biotherapeutics Inc (ATRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Find the latest Atara Biotherapeutics, Inc. (ATRA) stock quote, history, news and other vital information to help you with your stock trading and investing. View Atara Biotherapeutics Inc ATRA stock quote prices, financial information, real-time forecasts, and company news from CNN. Find the latest analyst research, reports, and ratings for Atara Biotherapeutics, Inc. Common Stock (ATRA) at oncologist-in.ru Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune. Thinking of buying or selling Atara Biotherapeutics Inc stock that's listed in a currency different from your local one? Use our international stock ticker. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. The current price of ATRA is USD — it has increased by % in the past 24 hours. Watch Atara Biotherapeutics, Inc. stock price performance more closely. Why Atara Biotherapeutics Stock Is Sinking Today. A fatality in an early-stage clinical trial is weighing on the cell therapy company's stock today. George.
Atara Biotherapeutics, Inc ATRA ; Loading chart ; About Atara Biotherapeutics, Inc (ATRA). Loading info ; Key Statistics. Loading info ; News. Loading info. Atara Biotherapeutics Inc ATRA:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/20/23 · 52 Week Low Valuation: Atara Biotherapeutics, Inc. ; P/E ratio * · EV / Sales * · Yield *. Atara Biotherapeutics Inc ; May, Downgrade, Citigroup, Buy → Neutral, $15 → $8 ; May, Upgrade, JP Morgan, Neutral → Overweight, $23 → $ Atara Biotherapeutics Inc (ATRA) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus.
Atara Biotherapeutics (ATRA) - Develops therapeutics for muscle-wasting conditions and oncology. · Atara Biotherapeutics Sees Relative Strength Rating Improve To. SECTOR, INDUSTRY, ACTIVITY ; Healthcare, Biotechnology & Medical Research, Bio Therapeutic Drugs.